Drug target gene-based analyses of drug repositionability in rare and intractable diseases
Abstract Drug development for rare and intractable diseases has been challenging for decades due to the low prevalence and insufficient information on these diseases. Drug repositioning is increasingly being used as a promising option in drug development. We aimed to analyze the trend of drug reposi...
Guardado en:
Autores principales: | Ryuichi Sakate, Tomonori Kimura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/43ce3b52f56b4575b6624b17c048893f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Integrative network analyses of transcriptomics data reveal potential drug targets for acute radiation syndrome
por: Robert Moore, et al.
Publicado: (2021) -
Mining the transcriptome for rare disease therapies: a comparison of the efficiencies of two data mining approaches and a targeted cell-based drug screen
por: A. J. Mears, et al.
Publicado: (2017) -
Role of biologics in intractable urticaria
por: Cooke A, et al.
Publicado: (2015) -
Choriocarcinoma in a viable pregnancy with the rare presentation of intractable lower back pain
por: Lulu Huang, et al.
Publicado: (2021) -
Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases
por: Kalpana Raja, et al.
Publicado: (2017)